What AARP Part D Plans Are Offered in 2025?
AARP offers Medicare Part D plans through UnitedHealthcare. Individuals do not have to be AARP members to enroll in these plans.
UnitedHealthcare partners with AARP to offer Medicare-eligible individuals two types of stand-alone Part D plans. These plans help cover the costs of prescription medications.
According to the nonprofit KFF, the estimated number of enrollees in AARP Part D plans in 2025 is around 2.8 million people. This makes the AARP and UnitedHealthcare partnership one of the most popular collaborations for stand-alone Part D plans.
The costs of these plans may vary based on an individual's location. Out-of-pocket costs may include premiums, deductibles, and copayments.
Glossary of common Medicare terms
Out-of-pocket cost: This is the amount you pay for care when Medicare doesn't pay the full cost or offer coverage. It includes premiums, deductibles, coinsurance, and copayments.
Premium: This is the monthly amount you pay for Medicare coverage.
Deductible: This is the annual amount you must spend out of pocket before Medicare begins to cover services and treatments.
Coinsurance: This is the percentage of treatment costs you're responsible for paying out of pocket. With Medicare Part B, you typically pay 20%.
AARP Part D plan coverage in 2025
All Medicare Part D plans, including AARP plans, have formularies (drug lists) that tell what drugs they cover.
AARP formularies are categorized into 5 different tiers:
Tier 1: includes preferred generic drugs
Tier 2: includes other generic drugs
Tier 3: includes preferred brand-name drugs
Tier 4: non-preferred drugs
Tier 5: specialty drugs
The copayments and coinsurance vary by tier and whether you use a preferred pharmacy.
AARP Part D plan costs in 2025
The costs of AARP Part D plans can vary depending on:
your location
your medications
your pharmacy (preferred pharmacies offer more savings)
When choosing a Part D plan, it is important to keep in mind that you will still be responsible for paying the Medicare Part A premium, if you have one, and the Part B premium of at least $185 per month. You also have to pay the Part A and Part B deductibles.
Part D plans will also include costs like premiums, deductibles, copayments, and coinsurance.
KFF notes that the monthly premium for the AARP Medicare Rx Preferred plan has decreased by $10 from the 2024 amount.
The following table gives examples of the 2025 monthly costs for AARP Medicare Rx Preferred plans in four different cities across the United States.
New York
(ZIP code: 10002) Atlanta
(ZIP code: 30308) Denver
(ZIP code: 80204) Seattle
(ZIP code: 98107)
Monthly premium $113.70 $100 $104.70 $83.80
Deductible $0 $0 $0 $0
Tier 1: Preferred generic drugs • preferred network pharmacy: $5 copay (30-daysupply)
• standard network pharmacy: $13 copay (30-day supply) • preferred network pharmacy: $5 copay (30-daysupply)
• standard network pharmacy: $13 copay (30-day supply) • preferred network pharmacy: $5 copay (30-daysupply)
• standard network pharmacy: $13 copay (30-day supply) • preferred network pharmacy: $5 copay (30-daysupply)
• standard network pharmacy: $13 copay (30-day supply)
Tier 2: Generic drugs • preferred network pharmacy: $10 copay (30-day supply)
• standard network pharmacy: $18 copay (30-day supply) • preferred network pharmacy: $10 copay (30-daysupply)
• standard network pharmacy: $18 copay (30-day supply) • preferred network pharmacy: $10 copay (30-daysupply)
• standard network pharmacy: $18 copay (30-day supply) • preferred network pharmacy: $10 copay (30-daysupply)
• standard network pharmacy: $18 copay (30-day supply)
Tier 3: Preferred brand drugs $47 copay (30-day supply)
$47 copay (30-day supply) $47 copay (30-day supply) $47 copay (30-day supply)
Tier 4: Non-preferred drugs • preferred network pharmacy: 40% of the cost (30-day supply)
• standard network pharmacy: 45% of the cost (30-day supply) • preferred network pharmacy: 40% of the cost (30-daysupply)
• standard network pharmacy: 45% of the cost (30-day supply) • preferred network pharmacy: 40% of the cost (30-daysupply)
• standard network pharmacy: 45% of the cost (30-day supply) • preferred network pharmacy: 40% of the cost (30-daysupply)
• standard network pharmacy: 45% of the cost (30-day supply)
Tier 5: Specialty drugs 33% of the cost (30-day supply) 33% of the cost (30-day supply) 33% of the cost (30-day supply) 33% of the cost (30-day supply)
The following table shows examples of 2025 costs for the AARP Medicare Rx Saver plan in the same four cities.
New York
(ZIP code: 10002) Atlanta
(ZIP code: 30308) Denver
(ZIP code: 80204) Seattle
(ZIP code: 98107)
Monthly premium $128.10 $82 $96.30 $37.40
Deductible (annual) $590 $590 $590 $590
Tier 1: Preferred generic drugs • preferred network pharmacy: $2 copay (30-daysupply)
• standard network pharmacy: $8 copay (30-day supply) • preferred network pharmacy: $2 copay (30-daysupply)
• standard network pharmacy: $8 copay (30-day supply) • preferred network pharmacy: $2 copay (30-daysupply)
• standard network pharmacy: $8 copay (30-day supply) • preferred network pharmacy: $2 copay (30-daysupply)
• standard network pharmacy: $8 copay (30-day supply)
Tier 2: Generic drugs • preferred network pharmacy: $8 copay (30-daysupply)
• standard network pharmacy: $10 copay (30-day supply) • preferred network pharmacy: $8 copay (30-daysupply)
• standard network pharmacy: $10 copay (30-day supply) • preferred network pharmacy: $8 copay (30-daysupply)
• standard network pharmacy: $10 copay (30-day supply) • preferred network pharmacy: $8 copay (30-daysupply)
• standard network pharmacy: $10 copay (30-day supply)
Tier 3: Preferred brand drugs 16% of the cost (30-day supply) 17% of the cost (30-day supply) 18% of the cost (30-day supply) 18% of the cost (30-day supply)
Tier 4: Non-preferred drugs • preferred network pharmacy: 40% of the cost (30-day supply)
• standard network pharmacy: 43% of the cost (30-day supply) • preferred network pharmacy: 44% of the cost (30-day supply)
• standard network pharmacy: 47% of the cost (30-day supply) • preferred network pharmacy: 43% of the cost (30-day supply)
• standard network pharmacy: 46% of the cost (30-day supply) • preferred network pharmacy: 40% of the cost (30-day supply)
• standard network pharmacy: 43% of the cost (30-day supply)
Tier 5: Specialty drugs 25% of the cost (30-day supply) 25% of the cost (30-day supply) 25% of the cost (30-day supply) 25% of the cost (30-day supply)
When choosing a plan, keep in mind that not all plans may have a preferred-network pharmacy in your area.
Medicare plan search tool
Medicare has its own online search tool. Using this tool, you can find Medicare Advantage and Part D plans available in your area from various companies.
You can search for plans by entering your ZIP code. This allows you to compare coverage and cost for various plans.
Frequently asked questions
Are prescription drugs covered by Medicare Part D?
Yes. Medicare Part D plans help cover the cost of prescription drugs. This includes both generic and brand-name medications.
Yes. Medicare Part D plans help cover the cost of prescription drugs. This includes both generic and brand-name medications.
Can you use AARP for prescriptions?
AARP partners with UnitedHealthcare to offer stand-alone Medicare Part D plans. There are two plans that both offer various coverage of prescriptions.
AARP partners with UnitedHealthcare to offer stand-alone Medicare Part D plans. There are two plans that both offer various coverage of prescriptions.
What is AARP Medicare Rx preferred from UHC PDP?
The AARP Medicare Rx Preferred plan from UnitedHealthcare (UHC) is one of the Medicare Part D plan options. These plans typically have higher monthly premiums but do not require you to pay an annual deductible before the plan begins paying for prescription drugs.
The AARP Medicare Rx Preferred plan from UnitedHealthcare (UHC) is one of the Medicare Part D plan options. These plans typically have higher monthly premiums but do not require you to pay an annual deductible before the plan begins paying for prescription drugs.
Get help from AARP–UnitedHealthcare
If you have questions about AARP Medicare Part D plans, you can contact UnitedHealthcare:
866-984-0682 (TTY: 771)
Find a UHC agent in your area
What is Medicare Part D?
Medicare Part D is a prescription drug plan. Part D plans help cover the costs of prescription drugs.
Those who are eligible for Medicare typically have two options for Part D coverage:
Medicare Advantage plan with prescription drug coverage
stand-alone Part D plan to go alongside Original Medicare
Costs for Part D plans vary by the insurance provider and your location. Some plans have deductibles you are required to meet before your plan starts paying.
When your out-of-pocket costs reach $2,000, you automatically enter catastrophic coverage. This means you will pay nothing for your prescriptions for the rest of the year.
»Learn more: Medicare Part D
Takeaway
AARP partners with UnitedHealthcare to offer Medicare Part D plans. There are two plan options — the preferred plan and the saver plan.
Costs and coverage may vary by the area you live in. You can find plan availability in your area by searching your ZIP code on either the AARP and UnitedHealthcare partnership website or the Medicare website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
2 hours ago
- Time Business News
Health Department Awards Optus $33M Contract for Medicare Communications Infrastructure
The Department of Health has awarded Australian telecommunications giant Optus a $33 million contract to provide critical communications services underpinning Australia's Medicare and e-health systems, marking a significant vote of confidence in the carrier following recent cybersecurity challenges. The three-year deal, with potential extension to six years, was confirmed through a contract notification posted on the government's AusTender procurement website. The agreement consolidates Optus's position as a strategic telecommunications provider to the federal government. Under the arrangement, Optus will deliver what the company describes as 'a fully managed Network-as-a-Service (NaaS) solution for the Department of Health, Disability and Ageing, supporting its digital transformation.' The contract represents a consolidation of various telecommunications services previously spread across multiple arrangements. Optus has historically maintained substantial portions of the Health Department's carrier contracts, but the new deal brings together disparate services under a unified framework. The award comes as the Albanese government prioritizes securing core digital infrastructure supporting Medicare and broader e-health services. The telecommunications backbone provided under the contract will underpin the delivery of essential health services to millions of Australians. The deal also signals renewed government confidence in Optus following a turbulent period for the carrier. The company was among several major Australian corporations targeted by Russian-linked ransomware attacks, drawing criticism from former Home Affairs Minister Clare O'Neil. The cyberattacks resulted in the application of sanctions following what officials described as malicious raids on critical infrastructure providers. Despite these security challenges, the Health Department's decision to award the substantial contract to Optus suggests the government views the carrier as having adequately addressed previous vulnerabilities. The Network-as-a-Service model allows the Health Department to access telecommunications infrastructure without the need for significant capital investment in physical network equipment, while ensuring reliable connectivity for critical health system operations. The contract timeline provides flexibility for both parties, with the initial three-year term allowing for performance evaluation before potential extension to the full six-year period. This structure enables the government to maintain service continuity while preserving options for future procurement decisions. TIME BUSINESS NEWS
Wall Street Journal
10 hours ago
- Wall Street Journal
Agency Overreach Leaves Patients Untreated
President Trump is pursuing deregulation to boost economic growth, but he could also use it to encourage medical innovation. As a first step, he could end the Coverage and Evidence Development program at the Centers for Medicare and Medicaid Services. CMS established the program two decades ago to speed Medicare coverage of new treatments that had been approved by the Food and Drug Administration. Instead, CED has slowed it down. In 2005 advances in medical devices were solving major medical problems, but CMS bureaucrats worried about taxpayer costs and demanded more data before covering them.
Yahoo
10 hours ago
- Yahoo
Global Healthy Living Foundation Peer-Reviewed Research Shows Hidden Risks of the Inflation Reduction Act's Drug Pricing Reform
Report reveals potential for higher patient costs, worse health outcomes despite lower "fair prices" UPPER NYACK, N.Y., June 10, 2025--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) has launched a research-backed public education campaign to raise awareness about the unintended consequences of drug pricing reforms under the Inflation Reduction Act (IRA). This initiative stems from a recent peer-reviewed paper co-authored by GHLF's Chief Science Policy Officer, Dr. Robert Popovian, Pharm.D., MS, published in the Journal of Health Economics and Outcomes Research (JHEOR). It includes a podcast episode, an infographic, and an article aimed at informing patients, caregivers, and policymakers. "The IRA's "maximum fair price" (MFP) policy was designed to reduce out-of-pocket costs for Medicare patients. However, it may lead to the opposite: higher out-of-pocket costs and increased health risks for vulnerable patients," report author Dr. Popovian says "By suppressing the retail price, CMS is reducing the profit margins and revenue for pharmacy benefit managers (PBMs), which is good. Predictably, the PBMs will not stand pat—they can shift the drug to a higher formulary tier, where patients will pay more out-of-pocket to acquire the medicine so the PBM can protect its profit margin," said Dr. Popovian in a recent episode of GHLF's Healthcare Matters podcast. The study specifically modeled outcomes for two widely used blood thinners, Eliquis and Xarelto. If PBMs reclassify these drugs to higher cost tiers to compensate for lost profit, patients could face an estimated $688 million more in out-of-pocket costs. This cost-shift could result in over 320,000 patients abandoning treatment, potentially leading to 145,000 major cardiovascular events and up to 97,000 deaths. "This research underscores a serious gap in how drug pricing reforms are being implemented and monitored," said Dr. Popovian. "Without proper oversight and transparency, policies that were meant to help patients could end up hurting them." The GHLF education campaign includes: A peer-reviewed paper published in JHEOR: "Could the Inflation Reduction Act Maximum Fair Price Hurt Patients?" A patient-friendly article: "Lower Prices, Higher Risk: How Drug Reform Could Backfire on Patients" published on GHLF's website and supported by social media A special podcast episode of Healthcare Matters, co-hosted by Dr. Popovian A downloadable infographic explaining the findings at-a-glance "This campaign is not about politics—it's about patients," said Seth Ginsberg, GHLF Co-Founder and President. "We want people to understand what's at stake when reforms don't account for the full complexity of our health care system." GHLF encourages policymakers, journalists, and patient advocates to explore these resources and consider how reforms like the IRA impact access to critical medications. About GHLF The Global Healthy Living Foundation is a U.S. based, 501(c)(3) nonprofit, international organization whose mission is to improve the quality of life for people with chronic illnesses by advocating for improved access to health care through education, patient-centered clinical research, support, advocacy, and economic and policy research. GHLF is also a staunch advocate for vaccines. The Global Healthy Living Foundation is the parent organization of CreakyJoints®, the international, digital community for millions of people living with arthritis and their supporters worldwide who seek education, support, activism, and patient-centered research in English, Spanish, and French. In addition to arthritis and autoimmune disorders, GHLF supports dermatology, gastroenterology, neurology, cardiology, oncology, infectious disease, rare disease, and pulmonary patients through a host of different programs and activities which draw more than 700,000 patients a month to GHLF websites and create more than 10 million impressions a month on seven social media platforms. In 2024, GHLF had more than 1 million views and listens with its patient-centered audio-visual content, found on YouTube and podcast platforms. GHLF never asks the public for donations, receiving funding instead through governments, non-governmental organizations, foundations, industry, family foundations, and GHLF Co-Founder Louis Tharp. Visit for more information. View source version on Contacts Louis Tharpltharp@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
